期刊文献+

慢性肾脏病患者氧化应激状态及其相关影响因素 被引量:19

Oxidative stress in patients with chronic kidney diseases and the related factors
下载PDF
导出
摘要 目的研究慢性肾脏病(CKD)患者的氧化应激状态及其相关影响因素。方法选择2008年7—12月在复旦大学附属中山医院肾内科诊断为CKD1~5期的住院患者73例(CKD组)以及10例同期在骨科住院行择期手术的无肾脏疾病患者(对照组),测定血浆晚期氧化蛋白产物(AOPP)、丙二醛(MDA)水平以及谷胱甘肽过氧化物酶(GSH-PX)、过氧化物歧化酶(SOD)活力。结果①与对照组相比,CKD组的血浆AOPP、MDA均显著增高(P值均<0.05),血浆GSH-PX、SOD显著降低(P值均<0.05)。按CKD分期分为5个亚组,5个CKD亚组间血浆AOPP、MDA、GSH-PX、SOD水平的差异均有统计学意义(P值均<0.05),其中AOPP、MDA随着肾功能减退而显著升高,GSH-PX、SOD随着肾功能减退而显著降低。②血浆AOPP水平与血总胆固醇呈正相关(r=0.897,P<0.05);血浆SOD活力与血总胆固醇(r=-0.985)、脂蛋白(a)(r=-0.90)呈负相关(P值均<0.05),与血红蛋白呈正相关(r=0.954,P<0.05);血浆GSH-PX活力与血总胆固醇(r=-0.954)、脂蛋白(a)(r=-0.935)呈负相关(P值均<0.05),与血红蛋白呈正相关(r=0.911,P<0.05);血浆MDA水平与血总胆固醇(r=0.763)及脂蛋白(a)(r=0.718)呈正相关(P值均<0.05)。③超敏C反应蛋白(hs-CRP)与血浆AOPP(r=0.961)、MDA(r=0.901)呈正相关(P值均<0.05),与SOD(r=-0.903)、GSH-PX(r=-0.875)呈负相关(P值均<0.05)。结论CKD患者存在过度氧化应激。氧化应激的强度随着肾功能的减退、血红蛋白水平的下降及脂代谢紊乱的加重而增加。CKD患者体内氧化应激与微炎症状态密切相关。 Objective To investigate the oxidative stress in patients with chronic kidney disease (CKD) and to evaluate the relationship between increased oxidative stress and decreased kidney function, etc. Methods According to the definition of CKD in K/DOQI (2006), 73 OKD patients, who were treated in our department during July 2008 and Dec. 2008, were enrolled in the present study. Ten patients who were to receive elective operation in the orthopeadic department during the same period were taken as controls. The hemoglobin, blood lipid profile, C-reactive protein, albumin, glutathione peroxidase (GSH-PX), superoxide dismutase (SOD), malonaldehyde (MDA) and advanced oxidative protein product (AOPP) were investigated. Results (1) Plasma AOPP and MDA were significantly higher in CKD group compared with those in control group (both P〈0.05). Plasma GSH-PX and SOD were significantly lower in OKD group compared with those in control group (both P 0.05). There were significant differences in the plasma AOPP, MDA, GSH-PX and SOD among five CKD stages (all P 〈0.05). Plasma AOPP and MDA increased with the progression of kidney function. Plasma SOD and GSH- PX decreased with the progression of kidney function. (2) Plasma AOPP correlated well with total cholesterol (r = 0. 897, P〈0.05) ; plasma SOD correlated well with total cholesterol ( r = - 0. 985), LP(a) ( r = 0.90) and HB ( r = 0. 954), (all P〈0.05) ; plasma GSH-PX correlated well with total cholesterol ( r = -- 0. 954), LP (a) ( r = - 0. 935)and HB ( r = 0.911, all P〈0.05). Plasma MDA correlated well with total cholesterol ( r = 0. 763) and LP(a) (r=0.718, both P〈O.05). (3) hs-CRP correlated well withAOPP (r=0.961), SOD (r=-0.903), GSH-PX (r=-0.875), andMDA(r=0.901, alIP〈0.05). Conclusion Oxidative stress widely exists in CKD patients, and it aggravates with the worsening of kidney function, anemia and disorder of lipid metabolism. The oxidative stress is closely related to micro-inflammation status of patients. (Shanghai Med J, 2009, 32: 787-790)
出处 《上海医学》 CAS CSCD 北大核心 2009年第9期787-790,共4页 Shanghai Medical Journal
基金 教育部国家重点学科211二期重大项目(07TC14007) 上海市科学技术委员会重大科技攻关项目(08dz1900602)
关键词 氧化应激 慢性肾脏病 晚期氧化蛋白产物 谷胱甘肽过氧化物酶 微炎症 Oxidative stress Chronic kidney disease Advanced oxidative protein product Glutathione peroxidase Micro-inflammation
  • 相关文献

参考文献12

  • 1Parfrey P S, Foley R N, Harnett J D, et al. Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int, 1996, 49:1428-1434.
  • 2Himmelfarb J, Stenvinkel P, Ikizler TA, et al. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int, 2002, 62: 1524-1538.
  • 3Locatelli F, Canaud B, Eckardt K U, et al. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant, 2003, 18: 1272-1280.
  • 4National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis, 2002, 39 (2 Suppl 1): S1-S266.
  • 5Witko-Sarsat V, Friedlander M, Nguyen Khoa T, et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol, 1998, 161: 2524-2532.
  • 6Vaziri N D, Oveisi F, Ding Y. Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney Int, 1998, 53:1748-1754.
  • 7Tepel M, Echelmeyer M, Orie NN, et al. Increased intracellular reactive oxygen species in patients with end-stage renal failure: effect of hemodialysis. Kidney Int, 2000, 58: 867-872.
  • 8Mimic-Oka J, Simic T, Djukanovic L, et al. Alteration in plasma antioxidant capacity in various degrees of chronic renal failure. Clin Nephrol, 1999, 51:233-241.
  • 9武强,刘郑荣.慢性肾功能不全病人中的氧化应激现象观察[J].实用医学杂志,2004,20(10):1160-1161. 被引量:8
  • 10Siems W, Quast S, Carluccio F, et al. Oxidative stress in cardio renal anemia syndrome: correlations and therapeutic possibilities. Clin Nephrol, 2003, 60(Suppl 1): S22-S30.

二级参考文献6

  • 1Foley RN, Parfrey PS, Samak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998, 32(Suppl 3):112- 119
  • 2Stenvinkel P, Heimburger O, Paultre F, et al. Strong association between malnutrition,inflammation and athersclerosis in chronic renal failure. Kidney Int, 1999, 55(5):1899-1911
  • 3Amann K, Ritz C, Adamczak M, et al. Why is coronary heart disease of uraemic patients so frequent and so devastating? Nephrol Dial Transplant ,2003,18(4) :631 - 640
  • 4Annu KM, Zilmer M, Fellstrom B. Endothelium-dependent vasodilation and oxidative stress in chronic renal failure: Impact on cardiovascular disease. Kidney Int Suppl, 2003, (84) :s50 - 53
  • 5中华医学会肾脏病分会透析移植登记工作组,钱家麒,张伟明,徐筱琪.1999年度全国透析移植登记报告[J].中华肾脏病杂志,2001,17(2):77-78. 被引量:441
  • 6余月明,侯凡凡,张训,刘俊,胡敏燕,杨凌,许顶立.慢性肾功能衰竭患者的高同型半胱氨酸血症[J].中华肾脏病杂志,2002,18(1):34-37. 被引量:45

共引文献7

同被引文献242

引证文献19

二级引证文献99

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部